Position
Squarepoint Ops LLC in Neumora Therapeutics, Inc.
Back to the book · All holders of NMRA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $25K$1.79 → $1.95
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 185.8K | $332.6K | — | — | — | 0.0% |
| Q1 2026 | 156.2K | $304.6K | $1.95 | $25K | −$53K | 0.0% |